- Home
- Products
Jemperli (Dostarlimab-gxly)
Jemperli (Dostarlimab-gxly)
- Medicine Name: Jemperli
- Generic Name: Dostarlimab-gxly
- Dosage Form & Strength: 500 mg/10 mL (50 mg/mL) injection in a single-dose vial
- Manufactured By: GlaxoSmithKline
Jemperli is an FDA-approved PD-1 immune checkpoint inhibitor indicated for the treatment of:
- Mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after prior platinum-based therapy
- dMMR solid tumors that have progressed following prior treatment and for which no satisfactory alternative treatments exist
Recommended Dosage:
- Dose 1 to 4: 500 mg every 3 weeks
- From Dose 5 onward: 1,000 mg every 6 weeks
- Administered via IV infusion over 30 minutes
- Continue treatment until disease progression or unacceptable toxicity
Immune-Mediated Adverse Reactions: May occur in any organ or tissue. Monitor closely and manage promptly.
Lab Monitoring: Assess thyroid function, liver enzymes, and creatinine at baseline and periodically.
Infusion-Related Reactions: Can be life-threatening. Slow or interrupt infusion based on severity.
Fetal Harm: May cause harm to unborn children. Use contraception during and for 4 months after treatment.
Transplant Risk: Increased risk of complications in patients undergoing allogeneic HSCT before or after treatment.
To Import Jemperli to India, You’ll Need:
- A valid prescription from an oncologist
- Diagnostic reports confirming dMMR status
- Government-issued photo ID
Order Confirmation:
- Order is confirmed upon receipt of all documents and import permit, if required
Availability: Available across Mumbai, Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Ahmedabad, Pune, and other major Indian cities. Also available for export to eligible countries through the Named Patient Program.
Contact for Enquiry or Order:
- 📞 WhatsApp / Phone: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Jemperli from certified and approved suppliers in the USA, Canada, Europe, and Australia. Every prescription is verified by a licensed pharmacist. Medicines are shipped from our fulfillment center in Ambernath, Thane District.
We ensure:
- Legal compliance
- Genuine medications
- Secure and timely international delivery
What is the generic name of Jemperli®?
Dostarlimab-gxly
Who manufactures Jemperli®?
GlaxoSmithKline
When was Jemperli® FDA approved?
April 22, 2021
What types of cancer is Jemperli® approved for?
Recurrent or advanced endometrial cancer and solid tumors with dMMR gene abnormalities
What’s the dosage form?
Injection: 500 mg/10 mL (50 mg/mL) for IV infusion
Common side effects?
Fatigue, nausea, anemia, diarrhea, constipation
How much does Jemperli® cost in India?
Price varies. Contact us via WhatsApp +91-99675 15602 or info@globalraremeds.com for latest rates
How to store Jemperli®?
Refrigerate at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze or shake.
Can I order Jemperli® online from India?
Yes. Global Rare Meds provides legal, safe access through the Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
